Neurobiology of Disease


Date: April 24, 2012 (Tuesday)
Time: 10 a.m.
Theme: Neurodegeneration (Alzheimer's, Parkinson's Disease)
Module: Toolbox
Session: Gene therapy: cells and viruses
Instructor: Jodie McBride, Staff Scientist, OPRC, OHSU
Objectives: This session will provide an overview of approaches to gene therapy, focusing on the use of viral-mediated gene transfer.
Study questions:
  1. What factors dictate which gene therapy strategy (viral vectors, stem cells, gene guns, etc) is best suited for a particular application?
  2. What dictates the tropism of viral vectors and how does this affect its application and potency in different regions of the brain/body?
  3. What are the benefits and limitations of viral gene therapy to the CNS?
  4. What are the obstacles to overcome when translating gene therapy from the bench top to the clinic?
  5. How does the immune system react to the presence of foreign stem cells, viral vectors used in gene therapy applications?
  6. What are the ethical/moral concerns of using gene therapy to treat disease in humans?
  1. Kay et al., Nature Medicine 7, 33-38, 2001
    Adobe Acrobat
  2. McBride et al., PNAS 103, 9345-9350, 2006
    Adobe Acrobat
  3. (optional) Müller et al., Nature Rev Neurosci 7, 75-84, 2006
    Adobe Acrobat